VELCADE for injection receives EU marketing authorisation for second-line use in multiple myeloma
...antation. With today's announcement, more multiple myeloma patients can hope to receive earlier access to VEL...ion (FDA) approval for second-line use in multiple myeloma in March of this year. It is indicated in the U.S. for patients who have received at least one prior...Thalidomide treatment proves better than conventional chemotherapy for multiple myeloma
...d for the treatment of advanced stages of multiple myeloma since the late 1990s, this is the first large stud... before the procedure. In this study, 100 multiple myeloma patients given Thal-Dex before transplant were compared to 100 patients given traditional chemothera...American Society of Hematology partners with major health organizations to launch patientINFORM.org
...ticles on diseases such as leukemia, lymphoma, and myeloma in a manner that helps them more fully understand the implications of the research. During its initial pilot phase, patient INFORM will focus on cancer, diabetes, heart disease, and stroke. In the future, patient INFORM will extend its services ...Cancer quest boosted by renewal
... The mission of the Society is to cure leukaemia, myeloma and non-Hodgkin's and Hodgkin's lymphomas. It is funded entirely by private donors....Trial at Jefferson shows new drug may help cancer patients who need stem cell transplants
... attempting to determine if patients with multiple myeloma or non-Hodgkin's lymphoma who received the drug AM... all of the 25 patients (10 patients with multiple myeloma and 15 patients with non-Hodgkin's lymphoma) given the drug combination could move enough cells from...Mayo Clinic Cancer Center receives SPORE grant for breast cancer research from NCI
...rostate cancer, and shares SPOREs for lymphoma and myeloma with other institutions. The NCI established the SPORE program in 1992 to promote interdisciplinary research and speed the transition of basic research findings from the laboratory to applied settings involving patients and populations. The program's...Immune therapy could treat leukemias, autoimmune diseases, transplant rejection
...ll proliferation causes such leukemias as multiple myeloma and acute lymphoblastic leukemia, and such autoimmune diseases as rheumatoid arthritis and lupus. The researchers, led by Professor and Chair of Immunology Thomas Tedder, Ph.D., reported their findings in the online Early Edition of the Proceedings ...Rapid restoration of immunity in immune-suppressed cancer patients using T-cell vaccines
(Philadelphia, PA) - Patients with multiple myeloma suffer from a malignant proliferation of plasma ce...ntary treatment currently approved is to vaccinate myeloma patients against pneumococcus, a common bacterial infection, a year after their transplantation. But...Promising advance in breast cancer research
...o have implications for prostate cancer, lymphoma, myeloma and other hematologic cancers. Paul Dent, Ph.D., associate professor of biochemistry and radiation oncology, led the team. This new study translates its 2002 research that showed early success in the lab and more recently was tested in animals. In t...Compound from marine bacteria shows potential as multiple myeloma therapy
...s to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than cur...ly in combination with other treatments. Multiple myeloma is a currently incurable cancer of the bone marrow that causes a plunge in the production of vital r...Amgen investigational therapy for bone loss, denosumab, show increased bone mineral density
...tment-induced bone loss, bone metastases, multiple myeloma and rheumatoid arthritis. "Because denosumab targets RANK Ligand, it functions in a way that is entirely different than other bone loss treatments," said Willard Dere, MD, senior vice president of global development and chief medical officer, Amgen...Thalidomide should be added to treatment combination for multiple myeloma
...andard combination of drugs used to treat multiple myeloma in elderly patients could improve event-free survi...rial in this week's issue of The Lancet. Multiple myeloma is a cancer that develops from cells in the bone marrow called plasma cells. Since 1960 oral melphal...How can we protect patients with weakened immune systems from influenza?
...those receiving stem cell transplants for multiple myeloma (a cancer originating in bone marrow) and patients with ovarian cancer receiving an experimental treatment--an anti-cancer vaccine made from dendritic cells. Carl June, M.D., director of translational research at Penn's Abramson Cancer Center, leads ...Scientists discover new genetic subtypes of common blood cancer
... out of a landscape of many DNA alterations in the myeloma genome, the researchers report in the April issue ... results "define new disease subgroups of multiple myeloma that can be correlated with different clinical outcomes," wrote the authors, led by Ronald DePinho, ...Studies unclear whether spinal cement procedure improves back pain
...bral bone in people with osteoporosis and multiple myeloma patients who suffer from severe bone tumors. "In principle, such treatment may prevent further fracture or collapse of the bone," the ECRI authors say. Compression fractures in the porous bone of the spine can cause pain and reduce mobility, and may...Mayo Clinic Cancer Center on the forefront of the fight against multiple myeloma
...oportion of patients with newly diagnosed multiple myeloma responded to the Thal/Dex combination compared to ...urvival are important. "The treatment of multiple myeloma is not as simple as just finding an initial therapy that works," said Dr. Rajkumar. "We continue to...REVLIMID(R) granted approval by FDA for treatment of multiple myeloma
...ethasone as a treatment for patients with multiple myeloma who have received at least one prior therapy. REVL...out additional cytogenetic abnormalities. Multiple myeloma is the second most common blood cancer in the United States, affecting approximately 50,000 people. ...New hope in cancer vaccines emerges as novel therapies are developed and tested
...ating, are for treatment of patients with multiple myeloma who are slated to receive a stem cell transplant from a matched donor. In this strategy, which will also be tested in patients at the NIH, stem cell donors will be vaccinated with the patient's tumor antigen. "The donor has a healthy immune system...Mayo Clinic: New recommendations for use of bisphosphonates in treatment of multiple myeloma
ROCHESTER, Minn. -- Mayo Clinic's multiple myeloma (MM) research team has jointly issued a consensus ... Mayo Clinic team provided recommendations for the myeloma patients for whom bisphosphonates are indicated. They said pamidronate should be the bisphosphonate......posed a new genetic diagnostic method for multiple myeloma (MM), a type of bone marrow cancer, which permits ...gy. A disease associated with old age Multiple myeloma is a disease which primarily affects persons above 60 years of age. In 2001 in Spain, 1716 new cases...